C4x Discovery Share Discussion Threads

[bloomberg2] 19/11/2021 12:59

Thinking the same alloa

[alloa2003] 19/11/2021 08:09

Interesting comment from the Chief Scientific Officer Craig Fox who is leaving the company next March:-

"I wish the team well as I move on to my next role and look forward to hearing about their next achievements"

[alloa2003] 19/11/2021 07:37

55p would be a nice start!

[bloomberg2] 18/11/2021 21:31

https://youtu.be/6gPzCWFcOfY4.13second in.

[toffeeman] 18/11/2021 11:56

There are significant stakes from the raise at 90p in 2018 - it needs to double from here for those to get out at break even.

[alloa2003] 18/11/2021 11:10

1aconic,

Thats a great summary of the situation - where we are and what might happen.

Like you I think the shares are terribly underrated and are still suffering from the disasterous first fund raising a couple of years ago. At the time they expected to raise funds at 40ish, instead institutions had them over a barrel and demanded 15p on the day the deal was going to be signed off - because of "market conditions". Credibility was shot after that although slowly it is being rebuilt.

As well as everything you mention, there is a large (friendly) shareholder mopping up stock and approaching the 29.99% limit without making an offer. I am not saying they will make a bid but if more progress is made, new molecule deals, milestone payments, new molecules in the pipeline (which is surely on the way) then why not make an opportunistic bid with management.

Due to the city's disinterest the company would end up with enough funding to take it to the next stage where new deals, milestaone payments and royalties could see this turn into a cash cow in the future. If this was to happen at a giveaway price then the city would only have itself to blame.

[1aconic] 18/11/2021 10:49

The full INDV trial results are (according to INDV) expected to be published by the end of their Q4. By my reckoning that's means before the end of Jan 2022. However, they've already announced that the phase one was promising and have already moved onto phase 2. What we don't however know is what milestone payments are triggered between phase one and phase two. C4XD are in a very healthy cash position at the moment and I don't personally see a scenario where another diluting fund raise would be needed in the next couple of years just for general expenses. However, the market might be prepared to give it a chunky re-rate if there was another healthy injection of cold hard cash from the INDV project milestone or another of the pipeline molecules being licensed. To my mind, that's one option for what's moving the share price currently. Also, C4XD seems currently to be very reasonably valued for an increasingly proven Biotech... you just have to compare it to the likes of Exsciencia for proof of that. All Clive Dix would have to do in the next results is to drop "progress with AI led technologies" into the report and you'd need a re-rate of 10x here to make it comparible to peers.

[alloa2003] 18/11/2021 09:48

Results due 5th December if my memory serves me right - or thereabouts.

Plus there may be trial news from INDV and there has been talk of another even bigger deal in the pipeline for a new molecule.

[mirabeau] 18/11/2021 09:25

this is breaking out

news due?

[alloa2003] 17/11/2021 19:27

Buyers still sniffing around

[alloa2003] 16/11/2021 21:36

Ticking up nicely - news soon?

[alloa2003] 15/11/2021 23:06

No sign of a partial retracement of recent rise yet

[bloomberg2] 11/11/2021 16:46

They can have mine for Pound a share !! Not too greedy

[alloa2003] 11/11/2021 16:21

Might we see some corporate activity in C4XD in the short to medium term? The largest shareholder is buying up any stock thats available and approaching the max 29.99% without making an offer. If the market refuses to appreciate the "value" offered by the C4XD system and the two deals so far, could you blame them for an opportunistic bid?

[bloomberg2] 11/11/2021 15:27

Nice recovery from this morning

[alloa2003] 10/11/2021 20:07

They just cant keep this one down at the minute

[alloa2003] 10/11/2021 13:37

The indiciation was - if I remember correctly - that the other late stage molecule would be the biggest deal to date. If its more than $400m that is potentially huge income!

[davemac3] 10/11/2021 12:22

there are 11 million euros in preclinical milestone payments from the Sanofi deal, some of that may come in first

[bloomberg2] 10/11/2021 12:20

Hopefully there next deal with biG Pharma will be materially higher

[bloomberg2] 10/11/2021 12:16

Ok makes sense

[alloa2003] 10/11/2021 12:02

No, they said it was sensitive information. It will be material so I would think we will hear in due course. Aside from that they cant hide it from the accounts lol

[bloomberg2] 10/11/2021 11:59

Yes!! Any idea what the next milestone payment is Alloa ?

[alloa2003] 10/11/2021 11:55

There will be a potentially large milestone payment at this stage?